Login / Signup

Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung Cancer.

Thomas Eldridge Stinchcombe
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
  • small cell lung cancer
  • healthcare
  • palliative care
  • locally advanced
  • quality improvement
  • advanced non small cell lung cancer
  • squamous cell carcinoma
  • epidermal growth factor receptor
  • tyrosine kinase
  • rectal cancer